Cannabis Investing Tetra Bio-Pharma Enters into Binding Term Sheet for Two Products with Panag Pharma
Ocular Therapeutixâ„¢ Announces Successful Topline Results from Phase 3 Clinical Trial of DEXTENZAâ„¢
Ocular Therapeutixâ„¢ Announces Presentation at the Ophthalmology Innovation Summit (OIS) at the American Society of Retina Specialists (ASRS)
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor